Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Westlake Village BioPartners

Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Health tech
  • Biotechnology
  • AI
  • Fintech
About
Westlake Village BioPartners is a pioneering biotechnology firm located in Westlake, dedicated to advancing the development of innovative non-opioid pain management solutions. With a strong focus on addressing the urgent need for safer analgesics, the company leverages cutting-edge research and a robust pipeline of therapeutic candidates. Recently, Westlake Village BioPartners demonstrated its leadership in the industry by spearheading a $135 million Series A financing round for Latigo Biotherapeutics, further solidifying its commitment to fostering groundbreaking advancements in healthcare. Through strategic investments and collaborations, the company aims to revolutionize pain treatment and enhance patient quality of life.
Min check size
$1M
Max check size
$30M
Fund size
NPS

Investment Thesis

Westlake Village BioPartners focuses on incubating and building life sciences companies, aiming to bring transformative therapies and technologies to patients. They emphasize entrepreneurial spirit, push the boundaries of science and technology, and work in partnership with entrepreneurs.
Lead investor
Co Invest
Number of exits
Preferred contact method
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp